Centre Hospitalier Régional d'Orléans
chr-orleans.frLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
126
Active
28
Phase 3
2
Total enrollment
29,183
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| expression of a panel | — | — | — | — | — | 1 | |
| Assessing maternal and lactational plasma CBD uptake at different stages of breastfeeding | — | — | — | — | — | 1 |
Next readouts
- 2027-10
- 2029-11-07
Top conditions
- Healthy12
- Parkinson Disease4
- Stroke4
- Multiple Sclerosis3
- Stroke, Acute3
- COVID-193
- Critical Illness3
- Intensive Care Unit3
Frequently asked questions about Centre Hospitalier Régional d'Orléans
- How many clinical trials does Centre Hospitalier Régional d'Orléans have on ClinicalTrials.gov?
- Centre Hospitalier Régional d'Orléans is listed as the lead sponsor on 126 clinical trials in ClinicalTrials.gov, 28 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Centre Hospitalier Régional d'Orléans's trials are in Phase 3?
- 2 of Centre Hospitalier Régional d'Orléans's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Centre Hospitalier Régional d'Orléans focus on?
- Centre Hospitalier Régional d'Orléans's most-studied conditions on ClinicalTrials.gov are Healthy, Parkinson Disease, Stroke, Multiple Sclerosis, Stroke, Acute.
- When are Centre Hospitalier Régional d'Orléans's next clinical trial readouts?
- Centre Hospitalier Régional d'Orléans has 2 upcoming primary-completion readouts tracked here; the soonest is “Cannabidiol Into Breastmilk”, expected around 2027-10.